Paid and presented by Medtronic. The growing application of digital health technologies is advancing the capabilities of insertable cardiac devices. The most recent iterations can connect to a ...

Medical technology giant Medtronic will purchase miniaturised heart device firm, Heartware, in a deal worth an estimated $1.1 billion. The deal will see Heartware’s expansive range of ...

Medical technology giant Medtronic will purchase miniaturised heart device firm, Heartware, in a deal worth an estimated $1.1 billion. The deal will see Heartware’s expansive range of ...

The U.S. Food and Drug Administration (FDA) has greenlighted Medtronic’s (NYSE:MDT) PulseSelect Pulsed Field Ablation (PFA) System targeted at a heart rhythm disorder called atrial fibrillation ...

Christensen, Clayton M. "We've Got Rhythm! Medtronic Corp.'s Cardiac Pacemaker Business (TN)." Harvard Business School Teaching Note 698-056, March 1998.

The HxM™ BT combines Zephyr’s patented BioHarness™ smart-fabric heart rate technology used in high-end professional markets, with speed and distance in a small, comfortable consumer device.

The National Heart Centre Singapore (NHCS) and Medtronic have signed a memorandum of understanding (MOU) to enhance clinical ...

The biggest stories of the day delivered to your inbox.

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...